Axonics Inc (AXNX)
67.58
-0.09
(-0.13%)
USD |
NASDAQ |
May 17, 16:00
67.58
0.00 (0.00%)
After-Hours: 20:00
Axonics SG&A Expense (Quarterly): 71.30M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 71.30M |
December 31, 2023 | 66.19M |
September 30, 2023 | 59.32M |
June 30, 2023 | 54.98M |
March 31, 2023 | 54.82M |
December 31, 2022 | 54.09M |
September 30, 2022 | 49.14M |
June 30, 2022 | 49.95M |
March 31, 2022 | 43.08M |
December 31, 2021 | 39.28M |
September 30, 2021 | 35.56M |
June 30, 2021 | 33.45M |
March 31, 2021 | 27.55M |
December 31, 2020 | 24.87M |
Date | Value |
---|---|
September 30, 2020 | 22.83M |
June 30, 2020 | 19.76M |
March 31, 2020 | 24.22M |
December 31, 2019 | 21.84M |
September 30, 2019 | 20.87M |
June 30, 2019 | 15.11M |
March 31, 2019 | 9.929M |
December 31, 2018 | 4.917M |
September 30, 2018 | 3.739M |
June 30, 2018 | 2.447M |
March 31, 2018 | 1.983M |
December 31, 2017 | 1.565M |
September 30, 2017 | 1.471M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
15.11M
Minimum
Jun 2019
71.30M
Maximum
Mar 2024
39.41M
Average
37.42M
Median
SG&A Expense (Quarterly) Benchmarks
Boston Scientific Corp | 1.364B |
Cutera Inc | 36.56M |
Stereotaxis Inc | 6.469M |
Electromed Inc | 8.374M |
Myomo Inc | 5.232M |